ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

  • P-ISSN2233-4203
  • E-ISSN2093-8950
  • ESCI, SCOPUS, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

Inhibitory Potential of Bilobetin Against CYP2J2 Activities in Human Liver Microsomes

Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2020, v.11 no.4, pp.113-117
https://doi.org/10.5478/MSL.2020.11.4.113
Zhexue Wu (Kyungpook National University)
Su-Nyeong Jang (BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
So-Young Park (BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
Nguyen Minh Phuc (BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
Kwang-Hyeon Liu (BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
  • 다운로드 수
  • 조회수

Abstract

Cytochrome P450 2J2 (CYP2J2) is a member of the cytochrome P450 superfamily, and is known to be arachidonic acid epoxygenase that mediates the formation of four bioactive regioisomers of epoxyeicosatrienoic acids (EETs). CYP2J2 is also involved in the metabolism of drugs such as albendazole, astemizole, danazol, ebastine, and terfenadine. CYP2J2 is highly expressed in the heart and cancer tissues. In this study, the inhibitory potential of ten natural products against CYP2J2 activity was evaluated using human liver microsomes and tandem mass spectrometry. Among them, bilobetin, which is a kind of biflavo-noid, exhibits a strong inhibitory effect against the CYP2J2-mediated astemizole O-demethylation (IC 50 = 0.73 µM) and terfena- dine hydroxylation (IC 50 = 0.89 µM). This result suggests that bilobetin can be used as strong CYP2J2 inhibitor in drug metabolism study.

keywords
bilobetin, CYP2J2, human liver microsomes, liquid chromatography-tandem mass spectrometry, natural products


투고일Submission Date
2020-12-13
수정일Revised Date
2020-12-29
게재확정일Accepted Date
2020-12-29
상단으로 이동

Mass Spectrometry Letters